Cargando…

Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies

Aberrant microRNA (miR) expression plays an important role in pathogenesis of different types of cancers, including B-cell lymphoid malignancies and in the development of chemo-sensitivity or -resistance in chronic lymphocytic leukemia (CLL) as well as diffuse large B-cell lymphoma (DLBCL). Ibrutini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapoor, Isha, Bodo, Juraj, Hill, Brian T., Almasan, Alexandru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575967/ https://www.ncbi.nlm.nih.gov/pubmed/34750354 http://dx.doi.org/10.1038/s41419-021-04353-9

Ejemplares similares

Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies
por: Kapoor, Isha, et al.
Publicado: (2019)

Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
por: Kapoor, Isha, et al.
Publicado: (2020)

Development of venetoclax for therapy of lymphoid malignancies
por: Zhu, Huayuan, et al.
Publicado: (2017)

miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies
por: Al-harbi, Sayer, et al.
Publicado: (2015)

USP14 is a deubiquitinase for Ku70 and critical determinant of non-homologous end joining repair in autophagy and PTEN-deficient cells
por: Sharma, Arishya, et al.
Publicado: (2020)

MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
por: Choudhary, G S, et al.
Publicado: (2015)

New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals
por: Stancu, Andreea Lucia, et al.
Publicado: (2014)

The race to stymie BTK: zanu zings
por: Kapoor, Prashant, et al.
Publicado: (2020)

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
por: Madanat, Yazan F, et al.
Publicado: (2016)

Atg7 cooperates with Pten loss to drive prostate cancer tumor growth
por: Santanam, Urmila, et al.
Publicado: (2016)

Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignancies
por: Drillis, Georgios, et al.
Publicado: (2021)

β-Catenin Is Required for Prostate Development and Cooperates with Pten Loss to Drive Invasive Carcinoma
por: Francis, Jeffrey C., et al.
Publicado: (2013)

Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease
por: Rip, Jasper, et al.
Publicado: (2019)

miRNA Pattern in Hypoxic Microenvironment of Kidney Cancer—Role of PTEN
por: Majewska, Aleksandra, et al.
Publicado: (2022)

Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK
por: Kueffer, Lauren E., et al.
Publicado: (2021)

Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors
por: Qi, Jialei, et al.
Publicado: (2023)

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL
por: Sharma, Shruti, et al.
Publicado: (2016)

Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes
por: Richards, Katherine E., et al.
Publicado: (2022)

GeneSet2miRNA: finding the signature of cooperative miRNA activities in the gene lists
por: Antonov, Alexey V., et al.
Publicado: (2009)

Deciphering the Complexity of 3D Chromatin Organization Driving Lymphopoiesis and Lymphoid Malignancies
por: Scourzic, Laurianne, et al.
Publicado: (2021)

Non-Covalent BTK Inhibitors—The New BTKids on the Block for B-Cell Malignancies
por: Lewis, Katharine L, et al.
Publicado: (2021)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022)

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN
por: Yu, Tao, et al.
Publicado: (2015)

miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN
por: Gong, Zhen-Hua, et al.
Publicado: (2019)

miRNA‐216 knockdown has effects to suppress osteosarcoma via stimulating PTEN
por: Jiang, Ping, et al.
Publicado: (2020)

Efficient miRNA Inhibitor with GO-PEI Nanosheets for Osteosarcoma Suppression by Targeting PTEN
por: Ou, Lingling, et al.
Publicado: (2020)

MiRNA-202-5p promotes Colorectal Carcinogenesis through suppression of PTEN
por: Huang, Jing, et al.
Publicado: (2021)

The Role of miRNA in Haematological Malignancy
por: Gounaris-Shannon, Stephanie, et al.
Publicado: (2013)

miRNAs in Normal and Malignant Hematopoiesis
por: Kotaki, Ryutaro, et al.
Publicado: (2017)

Differential impact of BTK active site inhibitors on the conformational state of full-length BTK
por: Joseph, Raji E, et al.
Publicado: (2020)

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2023)

Efficient miRNA Inhibitor with GO-PEI Nanosheets for Osteosarcoma Suppression by Targeting PTEN [Retraction]
Publicado: (2023)

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
por: Naeem, Aishath, et al.
Publicado: (2022)

Role of miRNAs in the progression of malignant melanoma
por: Mueller, D W, et al.
Publicado: (2009)

MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
por: Chen, Pan, et al.
Publicado: (2016)

Expression of miRNAs and Their Cooperative Regulation of the Pathophysiology in Traumatic Brain Injury
por: Hu, Zhonghua, et al.
Publicado: (2012)

miRNAs cooperate in apoptosis regulation during C. elegans development
por: Sherrard, Ryan, et al.
Publicado: (2017)

The Role of PTEN in Myeloid Malignancies
por: Morotti, Alessandro, et al.
Publicado: (2015)

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs: Effect of Akt/mTOR inhibition on PTEN expression
por: Wan, Linyan, et al.
Publicado: (2022)

Use of a 6-miRNA panel to distinguish lymphoma from reactive lymphoid hyperplasia
por: Kang, Juanjuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o4m9t2md36gk9osuof1hg4bkj8